Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Glantz

Showing results (11-20 of 16) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 16 results.
Journal of Pediatric Orthopedics|May 1, 1984
Contributory etiologic factor for talipes equinovarus in congenital myotonic dystrophy: comparative biopsy study of intrinsic foot musculature and vastus lateralis in two casesI M Siegel, B R Eisenberg, R H Glantz
JAMA|February 23, 1990
Bromide intoxication secondary to pyridostigmine bromide therapyD M Rothenberg, A S Berns, R Barkin, et al.
Advances in Neurology|January 1, 1987
Pergolide mesylate: four years experience in Parkinson's diseaseC M Tanner, C G Goetz, R H Glantz, et al.
Neurology|May 1, 1985
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolideC G Goetz, C M Tanner, R H Glantz, et al.
Archives of Neurology|January 1, 1988
Central nervous system magnetic resonance imaging findings in myotonic dystrophyR H Glantz, R B Wright, M S Huckman, et al.
Neurology|October 1, 1982
Pergolide mesylate and idiopathic Parkinson diseaseC M Tanner, C G Goetz, R H Glantz, et al.
Pageof 2

Showing results (11-20 of 16) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 16 results.
Journal of Pediatric Orthopedics|May 1, 1984
Contributory etiologic factor for talipes equinovarus in congenital myotonic dystrophy: comparative biopsy study of intrinsic foot musculature and vastus lateralis in two casesI M Siegel, B R Eisenberg, R H Glantz
JAMA|February 23, 1990
Bromide intoxication secondary to pyridostigmine bromide therapyD M Rothenberg, A S Berns, R Barkin, et al.
Advances in Neurology|January 1, 1987
Pergolide mesylate: four years experience in Parkinson's diseaseC M Tanner, C G Goetz, R H Glantz, et al.
Neurology|May 1, 1985
Chronic agonist therapy for Parkinson's disease: a 5-year study of bromocriptine and pergolideC G Goetz, C M Tanner, R H Glantz, et al.
Archives of Neurology|January 1, 1988
Central nervous system magnetic resonance imaging findings in myotonic dystrophyR H Glantz, R B Wright, M S Huckman, et al.
Neurology|October 1, 1982
Pergolide mesylate and idiopathic Parkinson diseaseC M Tanner, C G Goetz, R H Glantz, et al.
Pageof 2